Universe Pharmaceuticals (UPC) Receivables: 2020-2024
Historic Receivables for Universe Pharmaceuticals (UPC) over the last 5 years, with Sep 2024 value amounting to $18.7 million.
- Universe Pharmaceuticals' Receivables rose 44.63% to $18.7 million in Q3 2024 from the same period last year, while for Sep 2024 it was $63.5 million, marking a year-over-year decrease of 3.14%. This contributed to the annual value of $18.7 million for FY2024, which is 44.63% up from last year.
- Per Universe Pharmaceuticals' latest filing, its Receivables stood at $18.7 million for FY2024, which was up 44.63% from $12.9 million recorded in FY2023.
- Universe Pharmaceuticals' Receivables' 5-year high stood at $18.7 million during FY2024, with a 5-year trough of $11.5 million in FY2020.
- For the 3-year period, Universe Pharmaceuticals' Receivables averaged around $15.9 million, with its median value being $16.0 million (2022).
- Per our database at Business Quant, Universe Pharmaceuticals' Receivables fell by 19.03% in 2023 and then surged by 44.63% in 2024.
- Over the past 5 years, Universe Pharmaceuticals' Receivables (Yearly) stood at $11.5 million in 2020, then surged by 41.22% to $16.3 million in 2021, then decreased by 1.73% to $16.0 million in 2022, then dropped by 19.03% to $12.9 million in 2023, then surged by 44.63% to $18.7 million in 2024.